Chen, Mao et al. published their research in Angewandte Chemie, International Edition in 2013 |CAS: 38939-88-7

The Article related to benzotriazoles regioselective synthesis continuous flow, chloronitrobenzene amine tandem reaction cn coupling hydrogenation diazotization cyclization, Heterocyclic Compounds (More Than One Hetero Atom): Triazines and other aspects.Product Details of 38939-88-7

Chen, Mao; Buchwald, Stephen L. published an article in 2013, the title of the article was Continuous-flow synthesis of 1-substituted benzotriazoles from chloronitrobenzenes and amines in a C-N bond formation/hydrogenation/diazotization/cyclization sequence.Product Details of 38939-88-7 And the article contains the following content:

We have developed an efficient and regiospecific synthesis of 1-substituted benzotriazoles from chloronitrobenzenes and amines by a C-N bond formation/hydrogenation/diazotization/cyclization sequence under continuous-flow conditions. Two approaches beginning either with an SnAr reaction or Pd catalysis were developed to prepare unsym. substituted benzotriazoles with a range of substituents. Of particular note is that benzotriazoles that bear various N-substituted groups, including alkyl, aryl, and heteroaryl, can all be efficiently and regiospecifically accessed with the described method. This protocol represents a successful example of a continuous-flow method with consecutive multiphase processes. The experimental process involved the reaction of 2-Chloro-4-methyl-1-nitrobenzene(cas: 38939-88-7).Product Details of 38939-88-7

The Article related to benzotriazoles regioselective synthesis continuous flow, chloronitrobenzene amine tandem reaction cn coupling hydrogenation diazotization cyclization, Heterocyclic Compounds (More Than One Hetero Atom): Triazines and other aspects.Product Details of 38939-88-7

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Zou, Ying et al. published their research in Journal of Organic Chemistry in 2021 |CAS: 14602-86-9

The Article related to oxindole hydroxymethyl hydroxypyrazolyl asym synthesis, hydroxypyrazolyl oxindole enantioselective aldol condensation paraformaldehyde spiro pyrrolidine organocatalyst, Heterocyclic Compounds (More Than One Hetero Atom): Pyrazoles and other aspects.SDS of cas: 14602-86-9

On December 3, 2021, Zou, Ying; Huang, Zhi-Cheng; Xiang, Min; Li, Chen-Yi; Li, Xia; Tian, Fang; Wang, Li-Xin published an article.SDS of cas: 14602-86-9 The title of the article was Spiro-Scaffold Chiral Organocatalyst of 3,2′-Pyrrolidinyl Spiro-oxindole Amine and its Catalytic Evaluation in the Enantioselective Aldol Condensation between 3-(3-hydroxy-1H-pyrazol-1-yl)-Oxindole and Paraformaldehyde. And the article contained the following:

Spirocyclic chiral organocatalyst based on (R)-spiro[indoline-3,2′-pyrrolidine]-2-one was successfully prepared from racemic 1,2-dihydrospiro[indole-3,2′-pyrrolidine]-2-one using L-menthol as chiral auxiliary in 4 steps in 28%-40% overall yield with at least 99% ee in scale up preparation and its catalytic activity was evaluated in the enantioselective aldol condensation between 3-(3-hydroxy-1H-pyrazol-1-yl)oxindoles I (R1 = H, 5-Me, 5-MeO, 5-Cl, 7-Me; R2 = Me, H2C:CHCH2, n-Bu, Ph, PhCH2, 4-BrC6H4CH2) and paraformaldehyde. The spiro organocatalyst showed superior catalytic activity and selectivity compared with its counterparts, and most substrates offered good to excellent results with up to 96% yield and 96% ee. The experimental process involved the reaction of (1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl carbonochloridate(cas: 14602-86-9).SDS of cas: 14602-86-9

The Article related to oxindole hydroxymethyl hydroxypyrazolyl asym synthesis, hydroxypyrazolyl oxindole enantioselective aldol condensation paraformaldehyde spiro pyrrolidine organocatalyst, Heterocyclic Compounds (More Than One Hetero Atom): Pyrazoles and other aspects.SDS of cas: 14602-86-9

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Mu, Shuai et al. published their research in Journal of Heterocyclic Chemistry in 2015 |CAS: 99-60-5

The Article related to lixivaptan improved scalable impurity free synthesis, Heterocyclic Compounds (More Than One Hetero Atom): Diazepines and other aspects.Synthetic Route of 99-60-5

Mu, Shuai; Niu, Duan; Liu, Ying; Zhang, Dashuai; Liu, Dengke; Liu, Changxiao published an article in 2015, the title of the article was An Improved, Scalable and Impurity-Free Process for Lixivaptan.Synthetic Route of 99-60-5 And the article contains the following content:

An optimized synthetic method in high efficiency has been developed for the synthesis of lixivaptan from 2-nitrobenzyl bromide and pyrrole-2-carboxaldehyde. The byproducts among this procedure and an unknown impurity in crude product were investigated. The byproducts were speculated by 1H NMR or MS. The unknown impurity was characterized by 1H NMR, 13C NMR, and HRMS, confirming the structures as N-[3-chloro-4-(5H-pyrrolo[2,1-c][1,4]benzodiazepine-10(11H)-ylcarbonyl)phenyl]-N-(5-fluoro-2-methylbenzoyl)-5-fluoro-2-methylbenzamide. Afterwards, the impurity was synthesized to make comparisons. The target product lixivaptan was obtained with 47.6% overall yield and 99.93% purity. This cost-effective and environmentally friendly process is suitable for scale-up production The experimental process involved the reaction of 2-Chloro-4-nitrobenzoic acid(cas: 99-60-5).Synthetic Route of 99-60-5

The Article related to lixivaptan improved scalable impurity free synthesis, Heterocyclic Compounds (More Than One Hetero Atom): Diazepines and other aspects.Synthetic Route of 99-60-5

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Cockerill, G. Stuart et al. published their research in Journal of Medicinal Chemistry in 2021 |CAS: 5034-06-0

The Article related to sisunatovir analog drug discovery synthesis rsv antiviral, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Computed Properties of 5034-06-0

On April 8, 2021, Cockerill, G. Stuart; Angell, Richard M.; Bedernjak, Alexandre; Chuckowree, Irina; Fraser, Ian; Gascon-Simorte, Jose; Gilman, Morgan S. A.; Good, James A. D.; Harland, Rachel; Johnson, Sara M.; Ludes-Meyers, John H.; Littler, Edward; Lumley, James; Lunn, Graham; Mathews, Neil; McLellan, Jason S.; Paradowski, Michael; Peeples, Mark E.; Scott, Claire; Tait, Dereck; Taylor, Geraldine; Thom, Michelle; Thomas, Elaine; Villalonga Barber, Carol; Ward, Simon E.; Watterson, Daniel; Williams, Gareth; Young, Paul; Powell, Kenneth published an article.Computed Properties of 5034-06-0 The title of the article was Discovery of Sisunatovir (RV521), an Inhibitor of Respiratory Syncytial Virus Fusion. And the article contained the following:

RV521 is an orally bioavailable inhibitor of respiratory syncytial virus (RSV) fusion that was identified after a lead optimization process based upon hits that originated from a phys. property directed hit profiling exercise at Reviral. This exercise encompassed collaborations with a number of contract organizations with collaborative medicinal chem. and virol. during the optimization phase in addition to those utilized as the compound proceeded through preclin. and clin. evaluation. RV521 exhibited a mean IC50 of 1.2 nM against a panel of RSV A and B laboratory strains and clin. isolates with antiviral efficacy in the Balb/C mouse model of RSV infection. Oral bioavailability in preclin. species ranged from 42 to >100% with evidence of highly efficient penetration into lung tissue. In healthy adult human volunteers exptl. infected with RSV, a potent antiviral effect was observed with a significant reduction in viral load and symptoms compared to placebo. The experimental process involved the reaction of trimethyloxosulphonium chloride(cas: 5034-06-0).Computed Properties of 5034-06-0

The Article related to sisunatovir analog drug discovery synthesis rsv antiviral, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Computed Properties of 5034-06-0

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Mohideen, Abbas Khaja et al. published their research in Organic Communications in 2022 |CAS: 89-77-0

The Article related to benzodiazepine dione preparation green chem mol docking antitumor human, Heterocyclic Compounds (More Than One Hetero Atom): Diazepines and other aspects.SDS of cas: 89-77-0

Mohideen, Abbas Khaja; Mustaque, Kasim Mohammed; Meeran, Ismail Salim; Subramani, Annadurai; Ahamed, V. S. Jamal; Thajudeen, Habeebullah; Shabeer, Timiri Khudus published an article in 2022, the title of the article was Solvent-free synthesis, molecular simulation and cytotoxicity of 1,4-benzodiazepine-2,5-diones.SDS of cas: 89-77-0 And the article contains the following content:

The reaction of anthranilic acids with proline or pipecolic Me ester hydrochloride in presence of 1,1′-carbonyldiimidazole (CDI) on oil bath heating under solvent-free conditions afforded 1,4-benzodiazepine-2,5-dione (BZD) derivatives in moderate to good yields. Operational simplicity, absence of hazardous solvents, utility of an inexpensive coupling reagent (CDI) and mild reaction conditions are the significant advantages of this methodol. The cytotoxic activity of six BZDs were evaluated against HCT15 (Human Colon adenocarcinoma), SKMel2 (Human Skin Melanoma) and SKOV3 (Human Ovarian adenocarcinoma) cell lines. Compound I with p-Cl substitution showed moderate cytotoxicity against HCT15, SKMel2 and SKOV3 with IC50 values 37.04 +/- 1.13, 39.45 +/- 0.77 and 36.61 +/- 0.10μg/mL resp. The comprehensive anal. of the interaction between BZDs with receptor VEGFR-2 kinase, showed that compound I has higher mol. docking score with receptor. The experimental process involved the reaction of 2-Amino-4-chlorobenzoic acid(cas: 89-77-0).SDS of cas: 89-77-0

The Article related to benzodiazepine dione preparation green chem mol docking antitumor human, Heterocyclic Compounds (More Than One Hetero Atom): Diazepines and other aspects.SDS of cas: 89-77-0

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Anand, Keshav et al. published their research in International Journal of Pharmaceutical Sciences and Research in 2018 |CAS: 99-60-5

The Article related to benzimidazole preparation antibacterial antioxidant antifungal activity, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.HPLC of Formula: 99-60-5

Anand, Keshav; Wakode, Sharad published an article in 2018, the title of the article was Synthesis, characterization and biological evaluation of benzimidazole derivatives.HPLC of Formula: 99-60-5 And the article contains the following content:

A series of benzimidazole derivatives were synthesized by a single step process by reacting o-phenylenediamine and benzoic acid. The purity and structure confirmation of the synthesized compounds were done by TLC and 1H-NMR. The compounds were evaluated for anti-microbial, anti-fungal and antioxidant activity. The experimental process involved the reaction of 2-Chloro-4-nitrobenzoic acid(cas: 99-60-5).HPLC of Formula: 99-60-5

The Article related to benzimidazole preparation antibacterial antioxidant antifungal activity, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.HPLC of Formula: 99-60-5

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Simoneau, Bruno et al. published their patent in 2011 |CAS: 38939-88-7

The Article related to benzodiazepinedione preparation replication inhibitor treatment hiv infection, Heterocyclic Compounds (More Than One Hetero Atom): Diazepines and other aspects.Electric Literature of 38939-88-7

On August 25, 2011, Simoneau, Bruno; Deroy, Patrick; Fader, Lee; Faucher, Anne-Marie; Gagnon, Alexandre; Grand-Maitre, Chantal; Kawai, Steven; Landry, Serge; Mercier, Jean-Francois; Rancourt, Jean published a patent.Electric Literature of 38939-88-7 The title of the patent was 1-Phenyl-1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione derivatives as HIV replication inhibitors and their preparation and use for the treatment of HIV infection. And the patent contained the following:

The invention relates to benzodiazepinedione derivatives of formula I, which are HIV replication inhibitors and which are useful in the treatment of HIV infection. Compounds of formula I wherein X is C=O; Y is substituted CHPh, substituted benzo-fused spirocycle, substituted NPh, etc.; XY taken together to form (un)substituted 5-membered heteroaryl; each R1 is independently C1-6 alkyl, C1-6 haloalkyl, halo and C3-7 cycloalkyl; R2 is H, C1-6 alkyl, C1-6 alkyl-C3-7 cycloalkyl and C3-7 cycloalkyl; R3 is (un)substituted Ph and thiophene; m is 1 to 3; are claimed. Example compound II was prepared by a multistep procedure (procedure given). All the invention compounds were evaluated for their HIV replication inhibitory activity. From the assay, it was determined that compound II exhibited IC50 values in the range 0.38 – 047 μM and an EC50 value of 2.6 μM. The experimental process involved the reaction of 2-Chloro-4-methyl-1-nitrobenzene(cas: 38939-88-7).Electric Literature of 38939-88-7

The Article related to benzodiazepinedione preparation replication inhibitor treatment hiv infection, Heterocyclic Compounds (More Than One Hetero Atom): Diazepines and other aspects.Electric Literature of 38939-88-7

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Grewal, Gurmit et al. published their patent in 2008 |CAS: 38939-88-7

The Article related to preparation heterocyclic sulfonamide edg1 receptor antagonist treatment cancer, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.SDS of cas: 38939-88-7

On May 15, 2008, Grewal, Gurmit; Hennessy, Edward; Kamhi, Victor; Li, Danyang; Lyne, Paul; Oza, Vibha; Saeh, Jamel Carlos; Su, Qibin; Yang, Bin published a patent.SDS of cas: 38939-88-7 The title of the patent was Preparation of heterocyclic sulfonamide compounds as Edg-1 antagonists useful in the treatment of cancer. And the patent contained the following:

The invention relates to chem. compounds of formula I (wherein ring A is carbocyclyl or heterocyclyl; n = 0-5; R1 is halo, nitro, cyano, etc.; R2 is C1-6alkyl, carbocyclyl, etc.; R3 is H, C1-6alkyl, etc.; or alternatively, R2 and R3 together may form part of C3-6carbocyclic ring; R4 is C1-6alkyl or carbocyclyl; Ring D is a 5-7 membered ring; R5 is a substituent on carbon and is halo, nitro, cyano, etc.; m is 0-5) or pharmaceutically acceptable salts thereof, which possess Edg-1 antagonistic activity and are accordingly useful for their anti-cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chem. compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments for use in the production of an anti-cancer effect in a warm-blooded animal, such as man. Example compound II, prepared by reacting the appropriate sulfonyl chloride with [1-[1-(cyclopropylmethyl)-1H-benzimidazol-2-yl]ethyl]amine, caused 100% inhibition of Edg-1 receptor activity at 3.70 μM in an in vitro cell based receptor activation assay. The experimental process involved the reaction of 2-Chloro-4-methyl-1-nitrobenzene(cas: 38939-88-7).SDS of cas: 38939-88-7

The Article related to preparation heterocyclic sulfonamide edg1 receptor antagonist treatment cancer, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.SDS of cas: 38939-88-7

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Bogdan, Andrew et al. published their patent in 2015 |CAS: 490021-97-1

The Article related to quinolinecarboxamide heteroaryloxy aryloxy preparation sodium channel blocker pain, Heterocyclic Compounds (More Than One Hetero Atom): Diazepines and other aspects.Related Products of 490021-97-1

On August 6, 2015, Bogdan, Andrew; Cowart, Marlon D.; Degoey, David A.; Jinkerson, Tammie K.; Koenig, John R.; Kort, Michael E.; Liu, Bo; Matulenko, Mark A.; Nelson, Derek W.; Patel, Meena V.; Peltier, Hillary; Scanio, Marc J.; Wakefield, Brian D. published a patent.Related Products of 490021-97-1 The title of the patent was Preparation of 6-heteroaryloxy- or 6-aryloxyquinoline-2-carboxamides as sodium channel blockers. And the patent contained the following:

The invention is related to the preparation of title compounds I [R1 = (un)substituted Ph, 5-6 membered heteroaryl; R2 = H, alkyl, alkoxyalkyl, etc.; R3 = H, alkenyl, haloalkyl, etc.; or R2NR3 = (un)substituted 4-8 membered monocyclic heterocycle, 6-11 membered bicyclic heterocycle, 10-12 membered tricyclic heterocycle, 7-11 membered spirocyclic heterocycle or 8-11 membered bicyclic heteroaryl comprised of a monocyclic heterocycle fused to a monocyclic heteroaryl], pharmaceutically acceptable salts, esters, amides, and radiolabeled forms that are sodium channel blockers useful in treating conditions or disorders prevented by or ameliorated by voltage-gated sodium channels, e.g., Nav1.7 and/or Nav1.8. The invention is also related to pharmaceutical compositions containing I, and methods for using such compounds and compositions Thus, II was prepared by a multi-step synthesis starting from quinoline-2,6-diol. II was active in FRET-based membrane potential assays for human sodium channels Nav1.7 and Nav1.8. The experimental process involved the reaction of 3-(4-Chlorophenoxy)azetidine hydrochloride(cas: 490021-97-1).Related Products of 490021-97-1

The Article related to quinolinecarboxamide heteroaryloxy aryloxy preparation sodium channel blocker pain, Heterocyclic Compounds (More Than One Hetero Atom): Diazepines and other aspects.Related Products of 490021-97-1

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics

Igder, Aghil et al. published their research in RSC Advances in 2020 |CAS: 80-07-9

The Article related to polysulfone vortex fluidic device morphol thermal stability, Chemistry of Synthetic High Polymers: Organic Condensation and Step Polymerization and other aspects.Application In Synthesis of 4,4′-Sulfonylbis(chlorobenzene)

Igder, Aghil; Pye, Scott; Mohammed Al-Antaki, Ahmed Hussein; Keshavarz, Alireza; Raston, Colin L.; Nosrati, Ata published an article in 2020, the title of the article was Vortex fluidic mediated synthesis of polysulfone.Application In Synthesis of 4,4′-Sulfonylbis(chlorobenzene) And the article contains the following content:

Polysulfone (PSF) was prepared under high shear in a vortex fluidic device (VFD) operating in confined mode, and its properties compared with that prepared using batch processing. This involved reacting the pre-prepared disodium salt of bisphenol A (BPA) with a 4,4′-dihalodiphenylsulfone under anhydrous conditions. SEM (SEM) established that in the thin film microfluidic platform, the PSF particles are sheet-like, for short reaction times, and fibrous for long reaction times, in contrast to spherical like particles for the polymer prepared using the conventional batch synthesis. The operating parameters of the VFD (rotational speed of the glass tube, its tilt angle and temperature) were systematically varied for establishing their effect on the mol. weight (Mw), glass transition temperature (Tg) and decomposition temperature, featuring gel permeation chromatog. (GPC), differential scanning calorimetry (DSC) and thermal gravimetric anal. (TGA) resp. The optimal VFD prepared PSF was obtained at 6000 rpm rotational speed, 45° tilt angle and 160°C, for 1 h of processing with Mw ∼10 000 g mol-1, Tg ∼158°C and decomposition temperature ∼530°C, which is comparable to the conventionally prepared PSF. The experimental process involved the reaction of 4,4′-Sulfonylbis(chlorobenzene)(cas: 80-07-9).Application In Synthesis of 4,4′-Sulfonylbis(chlorobenzene)

The Article related to polysulfone vortex fluidic device morphol thermal stability, Chemistry of Synthetic High Polymers: Organic Condensation and Step Polymerization and other aspects.Application In Synthesis of 4,4′-Sulfonylbis(chlorobenzene)

Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics